Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-18-233144
Filing Date
2018-07-31
Accepted
2018-07-31 16:07:04
Documents
9
Period of Report
2018-09-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A d568690dpre14a.htm PRE 14A 302753
2 GRAPHIC g568690g13u48.jpg GRAPHIC 3285
3 GRAPHIC g568690g41i08.jpg GRAPHIC 3319
4 GRAPHIC g568690g62d33.jpg GRAPHIC 29678
5 GRAPHIC g568690g68w92.jpg GRAPHIC 55887
6 GRAPHIC g568690g77w35.jpg GRAPHIC 1697
7 GRAPHIC g568690g91g89.jpg GRAPHIC 3451
8 GRAPHIC g568690page1.jpg GRAPHIC 2763
9 GRAPHIC g568690page2.jpg GRAPHIC 3852
  Complete submission text file 0001193125-18-233144.txt   448117
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 033-80623 | Film No.: 18981175
SIC: 2835 In Vitro & In Vivo Diagnostic Substances